H. Lundbeck A/S
H. Lundbeck A/S (HLUBF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HLUBF · as of Jun 9, 2026
Key Statistics
Explore H. Lundbeck A/S Data
hlubf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
hlubf competitorsHLUBF
DNPUF
GEDSF
GZPHF
HKMPF
HKMPYStock Performance
Full HistoryAbout H. Lundbeck A/S
H. Lundbeck A/S is a biopharmaceutical firm dedicated to the discovery, development, manufacturing, and commercialization of pharmaceutical therapies primarily addressing psychiatric and neurological …
what is h. lundbeck a/s · hlubf stock overview · h. lundbeck a/s company profile · who is h. lundbeck a/s ceo · hlubf OTC · h. lundbeck a/s headquarters · h. lundbeck a/s business segments
About Stock Overview & Key Data
H. Lundbeck A/S (HLUBF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Jul 13, 2022. As of the latest trading session, HLUBF stock price is $5.37, with a market capitalization of $5.7B. The stock has returned +45.14% over the past 12 months and +0.37% year-to-date.
In fiscal year 2025, H. Lundbeck A/S reported revenue of $24.3B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, H. Lundbeck A/S (HLUBF) stock price is $5.37. The stock is traded on OTC under the ticker symbol HLUBF. The 52-week range is $3.70 – $6.41.